- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06464224
Extremes of Respiratory Effort in Weaning Failure From Mechanical Ventilation: a Prospective Observational Study
July 19, 2024 updated by: JOSE ROBERTO LAPA E SILVA, Universidade Federal do Rio de Janeiro
Are the Extremes of Respiratory Efforts During Assisted Ventilation Associated With Weaning Failure in Critical Ill Patients: a Prospective Observational Study
The presence of high levels of respiratory effort in patients under mechanical ventilation may worsen the adjacent lung injury even after adapting protective ventilation.
Primary outcome: To evaluate the failure rate of weaning from IMV and its relationship with the lower and upper extremes of respiratory effort and the upper extreme of dynamic pulmonary stress during the first 7 days of spontaneous ventilation.
Analyze the influence of these extremes based on the thresholds of Pocc, P0.1 and their derivatives Pmus, Ptp, din and MP: in relation to days off MV (in the 28-day interval); Total weaning time; Rate and time for tracheostomy; Length of stay in the ICU and hospital; In-hospital mortality rate.
CAAE: 78185823.4.0000.5249.
Prospective multicenter observational study, carried out in the ICUs of Glória D'or and Niteroi D'or hospitals, from January 2024 to July 2026, in patients over 18 years old, undergoing orotracheal intubation and IMV, in their first 7 days on spontaneous ventilation.
Hypothesis: Extremes of respiratory effort and dynamic pulmonary stress would be associated with a higher rate of weaning from IMV, as well as longer time on IMV and subsequent longer hospital stay.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Introduction: The presence of high levels of respiratory effort in patients under mechanical ventilation may worsen the adjacent lung injury even after adapting protective ventilation, potentially prolonging the MV period.
Primary outcome: To evaluate the failure rate of weaning from IMV and its relationship with the lower and upper extremes of respiratory effort and the upper extreme of dynamic lung stress during the first 7 days of spontaneous ventilation.
Secondary outcomes: Analyze the influence of these extremes based on the thresholds of Pocc, P0.1 and their derivatives Pmus, Ptp, din and MP: in relation to days off MV (in the 28-day interval); Total weaning time; Rate and time for tracheostomy; Length of stay in the ICU and hospital; evaluate the variation in ventilation distribution through electrical impedance tomography with the extremes of Pocc and Pmus; analyze the fraction of diaphragmatic thickening and diaphragmatic excursion through diaphragmatic ultrasound at the upper and lower levels of Pocc and Pmus; In-hospital mortality rate.
Methodology: CAAE: 78185823.4.0000.5249;
Prospective multicenter observational study, carried out in the ICUs of Glória D'or and Niteroi D'or Hospitals, from January 2024 to July 2026, in patients over 18 years old, undergoing orotracheal intubation and IMV, in their first 7 days on spontaneous ventilation, excluding if patients with neuromuscular disease; Phrenic nerve injury; MV for less than 24 hours; Previously tracheostomized patient; Age under 18; Use of neuromuscular blocker > 72h; COPD sufferer; Pregnancy; Patient under palliative care; COVID-19 pneumonia; Patients reintubated after extubation in this hospitalization for less than 3 weeks.
Statistical analysis: the sample calculation showed an estimated value of 50 patients for two candidate predictor variables; variables will be reported as mean (SD), median (IQ 25 - 75%) or absolute and relative frequencies.
The estimate of any association between variables of upper and lower extremes of effort and dynamic pulmonary stress, as well as the ventilatory parameters used will be evaluated with preliminary univariate analysis (chi-square test with Yates' correction or Fisher's exact test), followed by a model multivariate logistic regression analysis adjusted for all clinical variables at hospital admission.
Survival time, as well as hospital admission time until the event, will be analyzed using Kaplan-Meier estimates; the log-rank test will be used to compare groups.
Values of p < 0.05 will be considered statistically significant.
Hypothesis: Extremes of respiratory effort and dynamic pulmonary stress would be associated with a higher rate of weaning from IMV, as well as longer time on IMV and subsequent longer hospital stay.
Study Type
Observational
Enrollment (Estimated)
1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amanda Pereira da cruz
- Phone Number: 21971739472
- Email: amanda_pereiradacruz@yahoo.com.br
Study Contact Backup
- Name: Pedro Leme Silva
- Phone Number: 2183430442
- Email: pedroleme@biof.ufrj.br
Study Locations
-
-
-
Rio De Janeiro, Brazil, 22211230
- Recruiting
- Gloria D'or hospital
-
Contact:
- Amanda Pereira da cruz
- Phone Number: 21971739472
- Email: amanda_pereiradacruz@yahoo.com.br
-
Contact:
- Amanda Pereira da cruz
- Phone Number: 55 21971739472
- Email: amanda_pereiradacruz@yahoo.com.br
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients under mechanical ventilation in their first seven days in spontaneous ventilation
Description
Inclusion Criteria:
- Patients over 18 years old, admitted to the Glória D'or hospital, undergoing orotracheal intubation and invasive mechanical ventilation, in their first 7 years on spontaneous ventilation, who accept to participate in the study by signing the free and informed consent form (or by their legal responsible).
Exclusion Criteria:
• Neuromuscular disease;
- Phrenic nerve injury;
- MV for less than 24 hours;
- Previously tracheostomized patient;
- Age under 18;
- Use of neuromuscular blocker > 72h;
- COPD;
- Patients with pulmonary fibrosis;
- Pregnancy;
- Patient under palliative care;
- COVID-19 pneumonia;
- Patients reintubated after extubation in this hospitalization for less than 3 weeks.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
low respiratory effort
patients under low respiratory effort
|
patients under respiratory effort lower than -1,5 cmH2O (P0,1) and/or -7 cmH2O (Pocc)
|
|
high respiratory effort
patients under high respiratory effort
|
patients under respiratory effort higher than -3,5 cmH2O (P0,1) and/or -15 cmH2O (Pocc)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
weaning rate from mechanical ventilation
Time Frame: 2 years
|
weaning rate from mechanical ventilation (%)
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
days outside the MV (in the 28-day interval)
Time Frame: 2 years
|
days outside the MV (in the 28-day interval)
|
2 years
|
|
Total weaning time (first attempt until success)
Time Frame: 2 years
|
Total weaning time (first attempt until success) (days)
|
2 years
|
|
Rate and time for tracheostomy
Time Frame: 2 years
|
Rate and time for tracheostomy (%)
|
2 years
|
|
Length of stay in the ICU and hospital
Time Frame: 2 years
|
Length of stay in the ICU and hospital (days)
|
2 years
|
|
In-hospital mortality rate
Time Frame: 2 years
|
In-hospital mortality rate (%)
|
2 years
|
|
electrical impedance tomography
Time Frame: 2 years
|
spontaneous breathing trial failure rate (%) evaluated by electrical impedance tomography
|
2 years
|
|
diaphragmatic ultrassound
Time Frame: 2 years
|
spontaneous breathing trial failure rate (%) evaluated by diaphragmatic ultrassound
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Bruno Vilaça, manager of physical therapy team
- Study Chair: Bruno Guimarães, manager of physical therapy team
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2024
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
July 1, 2026
Study Registration Dates
First Submitted
June 12, 2024
First Submitted That Met QC Criteria
June 12, 2024
First Posted (Actual)
June 18, 2024
Study Record Updates
Last Update Posted (Actual)
July 23, 2024
Last Update Submitted That Met QC Criteria
July 19, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 78185823.4.0000.5249
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weaning Failure
-
National Cancer Institute, EgyptCompletedWeaning Failure | Successful WeaningEgypt
-
Hospital do CoracaoNot yet recruitingWeaning Failure | Weaning From Mechanical Ventilation | Weaning From Mechanical Ventilation, Extubation
-
Cairo UniversityCompletedWeaning Failure | Weaning From Mechanical Ventilation | Mechanical VentilationEgypt
-
Ain Shams UniversityUnknown
-
Beni-Suef UniversityUnknown
-
Ain Shams UniversityCompleted
-
Cairo UniversityCompleted
-
Hôpital d'enfants Béchir-HamzaUnknownWeaning FailureTunisia
-
Hospital Israelita Albert EinsteinCompletedWeaning FailureBrazil
Clinical Trials on low respiratory effort
-
University of New MexicoActive, not recruiting
-
University of New MexicoActive, not recruitingPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)United States
-
University of New MexicoActive, not recruitingType 2 Diabetes Mellitus | PreDiabetesUnited States
-
University of Turin, ItalyCompletedMechanical Ventilation Complication | COVID-19 Respiratory Infection | Weaning Failure | ARDS, Human | COVID-19 Acute Respiratory Distress Syndrome | Respiratory Effort-Related Arousal | Acute Hypoxic Respiratory FailureItaly
-
University of California, San DiegoEnrolling by invitationRespiratory Failure | Pulmonary Disease | Breathing Mechanics | Respiratory EffortUnited States
-
Assistance Publique - Hôpitaux de ParisEurofins BiomnisNot yet recruiting
-
Kitani, Lenore, PTCompleted
-
Ramathibodi HospitalCompletedARDS | Sedation | Mechanical Ventilation Complication | Respiratory EffortThailand
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto AlegreUnknownFatigue | Dyspnea | Muscle Strength | Functional Capacity
-
Loewenstein HospitalAriel UniversityUnknownChronic Pain | Traumatic Brain Damage